APOE ε4 carriage associates with improved myocardial performance from adolescence to older age

Bibliographic Details
Title: APOE ε4 carriage associates with improved myocardial performance from adolescence to older age
Authors: Constantin-Cristian Topriceanu, Mit Shah, Matthew Webber, Fiona Chan, Hunain Shiwani, Marcus Richards, Jonathan Schott, Nishi Chaturvedi, James C. Moon, Alun D. Hughes, Aroon D. Hingorani, Declan P. O’Regan, Gabriella Captur
Source: BMC Cardiovascular Disorders, Vol 24, Iss 1, Pp 1-17 (2024)
Publisher Information: BMC, 2024.
Publication Year: 2024
Collection: LCC:Diseases of the circulatory (Cardiovascular) system
Subject Terms: Apolipoprotein ε4, Cardiovascular disease, Myocardial contraction fraction, Diseases of the circulatory (Cardiovascular) system, RC666-701
More Details: Abstract Background Although APOE ε4 allele carriage confers a risk for coronary artery disease, its persistence in humans might be explained by certain survival advantages (antagonistic pleiotropy). Methods Combining data from ~ 37,000 persons from three older age British cohorts (1946 National Survey of Health and Development [NSHD], Southall and Brent Revised [SABRE], and UK Biobank) and one younger age cohort (Avon Longitudinal Study of Parents and Children [ALSPAC]), we explored whether APOE ε4 carriage associates with beneficial or unfavorable left ventricular (LV) structural and functional metrics by echocardiography and cardiovascular magnetic resonance (CMR). Results Compared to the non-APOE ε4 group, APOE ε4 carriers had similar cardiac phenotypes in terms of LV ejection fraction, E/e’, posterior wall and interventricular septal thickness, and LV mass. However, they had improved myocardial performance resulting in greater LV stroke volume generation per 1 mL of myocardium (higher myocardial contraction fraction). In NSHD (n = 1467) and SABRE (n = 1187), ε4 carriers had a 4% higher MCF (95% CI 1–7%, p = 0.016) using echocardiography. Using CMR data, in UK Biobank (n = 32,972), ε4 carriers had a 1% higher MCF 95% (CI 0–1%, p = 0.020) with a dose-response relationship based on the number of ε4 alleles. In addition, UK Biobank ε4 carriers also had more favorable radial and longitudinal strain rates compared to non APOE ε4 carriers. In ALSPAC (n = 1397), APOE ε4 carriers aged
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1471-2261
Relation: https://doaj.org/toc/1471-2261
DOI: 10.1186/s12872-024-03808-z
Access URL: https://doaj.org/article/11cdd86813114bbcb62a5c1ef1c08698
Accession Number: edsdoj.11cdd86813114bbcb62a5c1ef1c08698
Database: Directory of Open Access Journals
More Details
ISSN:14712261
DOI:10.1186/s12872-024-03808-z
Published in:BMC Cardiovascular Disorders
Language:English